DNA.am
Develops Manufacturing Execution System (MES) software specifically for additive manufacturing, providing end-to-end workflow management, material traceability, and compliance for serial production
- CEO / Founder
- Tom Dawes
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- £960k
- Latest Round
- Grant
- Key Investors
- Innovate UK
Technology & Products
Key Products
DNA.am MES Platform; GROW.am IP Protection Module; Integrated Build Analytics
Technological Advantage
Proprietary workflow automation reduces manual intervention by 70% compared to generic MES systems; Integrated material tracking achieves 99.9% traceability compliance for regulated industries
Differentiation
Value Proposition
Reduces AM production costs by 30-40% through optimized build planning and material utilization, cuts lead times from weeks to days with automated workflows, and ensures regulatory compliance (AS9100, NADCAP) with complete digital traceability
How They Differentiate
3x faster implementation than Materialise Streamics (4 weeks vs 12 weeks) with 40% lower total cost of ownership; Unlike generic MES from Siemens or Autodesk, DNA.am offers AM-specific features like powder batch management and build plate optimization
Market & Competition
Target Customers
Aerospace OEMs, automotive manufacturers, medical device companies, AM service bureaus, and research organizations
Industry Verticals
Aerospace; Defense; Automotive; Medical; Industrial Manufacturing
Competitors
Materialise; 3D Systems; Siemens; Autodesk
Growth & Milestones
Growth Metrics
Expanded from UK to Central Europe, India and North America within 3 years; Customer base includes 4 Fortune 500 companies and 15+ AM service bureaus
Major Milestones
2017: MES platform launched with Airbus UK pilot; 2020: Acquired GROW.am for IP protection; 2021: Partnership with Dyndrite for mass customization; 2022: Strategic expansion into Asian markets
Notable Customers
Airbus; Safran; WiPro; RICOH; Zenith Tecnica